Skip to Main Content

Paper Details

Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody.
Science
228
2021
ADG-2, COVID-19, SARS, SARS-CoV, SARS-like viruses, coronaviruses, human, mouse, receptor binding site, sarbecoviruses, severe acute respiratory syndrome coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies
Author NameAffiliation
Bronwyn M GunnWashington State University
Jason S McLellanThe University of Texas at Austin
Ralph S BaricThe University of North Carolina at Chapel Hill
Ralph S BaricThe University of North Carolina at Chapel Hill
Ralph S BaricThe University of North Carolina at Chapel Hill
Ralph S BaricThe University of North Carolina at Chapel Hill
Lisa E GralinskiThe University of North Carolina at Chapel Hill
Lisa E GralinskiThe University of North Carolina at Chapel Hill
  • 1 - 8

Datasets

Release 1.2